MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA issued a public health advisory to alert health care professionals,
patients and their caregivers of reports of death and other serious side
effects from overdoses of fentanyl in patients using fentanyl transdermal
(skin) patches for pain control. Deaths and overdoses have occurred in
patients using both the brand name product Duragesic and the generic
product. Some patients and health care providers may not be fully aware of
the dangers of this very strong narcotic painkiller. The directions for
using the fentanyl skin patch must be followed exactly to prevent death or
other serious side effects from overdosing with fentanyl.

Read the MedWatch safety summary, including links to the Public Health
Advisory, Healthcare Professional and Patient Information Sheets, and the
Drug Information Page at:

http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#Fentanyl

Stephen Miles Sacks, Ph.D.
Editor and Publisher
SCIPOLICY-The Journal of Science and Health Policy
Box 504, Haverford, PA 19041
Telephone: 610-660-0220
Fax: 610-660-0120
Website: http://Scipolicy.net
E-mail: editor@...
and
Owner/Moderator ResearchEvaluation-L Discussion Group
Owner/Moderator ThePayoff-L Discussion Group
Owner/Moderator Scipolicy-L Discussion Group
Owner/Moderator CounterTerrorism-L Discussion Group


[Non-text portions of this message have been removed]